In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Elf Aquitaine's Sanofi merges with Synthlabo

Executive Summary

In a merger of France's second and third largest pharmaceutical companies, Elf Aquitaine's Sanofi drug unit ($19bn market cap) and L'Oreal SA's Synthlabo ($10.5bn market cap) will form a new drug company called Sanofi-Synthlabo (S-S).
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register